Showing results 1 to 60 of 67
|A phase 2 multi-center, open-label, switch-over trial to evaluate the safety and efficacy of Abcertin® in patients with type 1 Gaucher disease.
|A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer.
|A Recombinant Ig Fragment (IgCw-gek) Comprising the Cg1-Ce2-4 and Ck Domains Is an Alternative Reagent to Human IgE
|권명희, 김민재, 서영실
|Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2.
|Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective.
|Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.
|Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway.
|Applications of the immunoglobulin Cw fragment (IgCw) composed of the constant regions of heavy and light (CH and CL) chains
|Bacterial production and structure-functional validation of a recombinant antigen-binding fragment (Fab) of an anti-cancer therapeutic antibody targeting epidermal growth factor receptor
|Biologic response of degenerative living human nucleus pulposus cells to treatment with cytokines.
|Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
|Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
|Case report of an inhibitor patient treated with recombinant factor VIII.
|CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF-/- mice.
|Chemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein-expressing liver cells.
|박선, 이재호, 조혜성
|Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
|송지훈, 이기황, 이은소, 정유리
|Comparison of the Incidence of parenchymal hematoma and poor outcome in patients with carotid terminus occlusion treated with intra-arterial urokinase alone or with combined IV rtPA and intra-arterial urokinase
|김선용, 신동훈, 이진수, 임용철, 주인수, 홍지만
|Cross‑reactivity between group-5 and -21 mite allergens from Dermatophagoides farinae, Tyrophagus putrescentiae and Blomia tropicalis.
|Delayed transplantation with exogenous neurotrophin administration enhances plasticity of corticofugal projections after spinal cord injury.
|Development of Monoclonal Antibodies for Diagnosis of Plasmodium vivax
|Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells.
|김경민, 박선, 신호준
|Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients
|김형규, 안영실, 윤준기, 이수진, 이정훈
|Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial
|Effects of secreted frizzled-related protein 3 on osteoblasts in vitro.
|Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.
|Efficacy and safety of sustained-release recombinant human growth hormone in Korean adults with growth hormone deficiency.
|Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial
|Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity
|박해심, 정근옥, 최영우
|Enzymatic methylation of recombinant TIS21 protein-arginine residues.
|Exogenous bone morphogenetic protein-7 fails to attenuate renal fibrosis in rats with overload proteinuria.
|Extracellular Matrix (ECM) Multilayer Membrane as a Sustained Releasing Growth Factor Delivery System for rhTGF-beta3 in Articular Cartilage Repair
|Fowlerstefin, a cysteine protease inhibitor of Naegleria fowleri, induces inflammatory responses in BV-2 microglial cells in vitro
|GLP1 improves palmitateinduced insulin resistance in human skeletal muscle via SIRT1 activity
|강엽, 김대중, 김혜진, 이관우, 전자영, 최성이, 한승진
|Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity.
|Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine gamma-lyase degradation
|Identification of protein-arginine N-methyltransferase as 10-formyltetrahydrofolate dehydrogenase.
|Identification of the amino acid sequence motif of alpha-synuclein responsible for macrophage activation.
|Immunological characterizations of a cloned 13.1-kilodalton protein from pathogenic Naegleria fowleri.
|김경민, 김형일, 박선, 손성향, 신호준
|Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid.
|Intracellular trafficking and metabolic turnover of yeast prepro-alpha-factor-SRIF precursors in GH3 cells.
|Iron chelation-induced senescence-like growth arrest in hepatocyte cell lines: association of transforming growth factor beta1 (TGF-beta1)-mediated p27Kip1 expression.
|윤계순, 이재호, 임인경, 조혜성
|Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.
|Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
|Molecular cloning and characterization of a gene encoding a 13.1 kDa antigenic protein of Naegleria fowleri.
|김형일, 박선, 신호준
|Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation.
|Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population.
|Negative regulation of the SAPK/JNK signaling pathway by presenilin 1.
|Novel cathepsin B and cathepsin B-like cysteine protease of Naegleria fowleri excretory-secretory proteins and their biochemical properties.
|김경민, 박선, 손혜진, 신호준, 최용준
|Origin of myofibroblasts in the fibrotic liver in mice.
|Patterns of plasma fatty acids in rat models with adenovirus infection.
|백만정, 신규태, 안영환, 이광
|Pharmacokinetic and Pharmacodynamic Comparison of Two Recombinant Human Erythropoietin Formulations, PDA10 and Eprex, in Healthy Korean Male Volunteers: A Randomized, Double-Blinded, Single-Dose, Two-Period Crossover Study.
|Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
|Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death.
|Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
|Proapoptotic effects of tau cleavage product generated by caspase-3.
|Production and characterization of monoclonal antibodies against cathepsin B and cathepsin B-Like proteins of Naegleria fowleri
|Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
|Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial
|Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation
|Risk Factors for Indeterminate Response After Radioactive Iodine Therapy in Patients With Differentiated Thyroid Cancer
|소의영, 안영실, 윤준기, 이수진, 이정훈